Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000312069-26-000249·Aldeyra Therapeutics, Inc.
Schedule 13G ownership disclosure
Aldeyra Therapeutics Inc
COMMON-STOCK · CUSIP: 01438T106
Event date: 2026-09-30
- Filing-level shares
- 3,310,587
- Percent of class
- 5.48%
- Barclays PLC
Shares: 3,310,587 · Class: 5.48%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000312069-26-000249
- Form type
- SCHEDULE 13G
- Filer
- Aldeyra Therapeutics, Inc.
- CIK
- CIK 1341235
- Filed
- Nov 06, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership